These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9628219)
1. Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. de Swart RL; Vos HW; UytdeHaag FG; Osterhaus AD; van Binnendijk RS J Virol Methods; 1998 Mar; 71(1):35-44. PubMed ID: 9628219 [TBL] [Abstract][Full Text] [Related]
2. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672 [TBL] [Abstract][Full Text] [Related]
3. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity. Bouche F; Ammerlaan W; Berthet F; Houard S; Schneider F; Muller CP J Clin Microbiol; 1998 Mar; 36(3):721-6. PubMed ID: 9508302 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of hemagglutinin protein-specific immunoglobulin M for diagnosis of measles by an enzyme-linked immunosorbent assay based on recombinant protein produced in a high-efficiency mammalian expression system. Bouche FB; Brons NH; Houard S; Schneider F; Muller CP J Clin Microbiol; 1998 Dec; 36(12):3509-13. PubMed ID: 9817863 [TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303 [TBL] [Abstract][Full Text] [Related]
6. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles. Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066 [TBL] [Abstract][Full Text] [Related]
7. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946 [TBL] [Abstract][Full Text] [Related]
8. A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees. Bouche F; Ammerlaan W; Fournier P; Schneider F; Muller CP J Virol Methods; 1998 Sep; 74(1):77-87. PubMed ID: 9763131 [TBL] [Abstract][Full Text] [Related]
9. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection. Schlereth B; Germann PG; ter Meulen V; Niewiesk S J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075 [TBL] [Abstract][Full Text] [Related]
11. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies. Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158 [TBL] [Abstract][Full Text] [Related]
12. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. El Mubarak HS; Yüksel S; van Amerongen G; Mulder PGH; Mukhtar MM; Osterhaus ADME; de Swart RL J Gen Virol; 2007 Jul; 88(Pt 7):2028-2034. PubMed ID: 17554037 [TBL] [Abstract][Full Text] [Related]
13. Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus. Roodbari F; Roustai MH; Mostafaie A; Soleimanjdahi H; Foroshani RS; Sabahi F Clin Diagn Lab Immunol; 2003 May; 10(3):439-42. PubMed ID: 12738645 [TBL] [Abstract][Full Text] [Related]
14. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. de Swart RL; Yüksel S; Osterhaus AD J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210 [TBL] [Abstract][Full Text] [Related]
15. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Taylor J; Weinberg R; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E Virology; 1992 Mar; 187(1):321-8. PubMed ID: 1736535 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. Erdman DD; Anderson LJ; Adams DR; Stewart JA; Markowitz LE; Bellini WJ J Clin Microbiol; 1991 Jul; 29(7):1466-71. PubMed ID: 1885743 [TBL] [Abstract][Full Text] [Related]
17. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins. Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799 [TBL] [Abstract][Full Text] [Related]
18. [The immunoassay of IgM antibodies in samples clinically suspected of measles]. Ribas Antúnez MA; Arocha Rosete Y; Toraño Canto I; Rodríguez Valdés C Rev Cubana Med Trop; 1998; 50(2):105-9. PubMed ID: 10349427 [TBL] [Abstract][Full Text] [Related]
19. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies. de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253 [TBL] [Abstract][Full Text] [Related]